{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:19:19Z","timestamp":1772025559307,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"departmental resources"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To investigate the role of microRNA-29 (miR-29) in mice with allergic rhinitis (AR) and its underlying mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>AR model was established in BALB\/c mice by intraperitoneal sensitization and intranasal challenge with ovalbumin (OVA). miRNA expression was examined in the nasal mucosa tissues of mice and patients with AR, and miRNA-29 was found to be downregulated. To unveil the role of miRNA-29 in AR, it was overexpressed in the nasal mucosa of AR mice by intranasal administration of miRNA-29 agomir. The symptoms of nasal rubbing and sneezing were recorded and evaluated. miR-29 expression, OVA-specific immunoglobulin E (IgE) concentration, pro-inflammatory cytokines levels, eosinophils number, and cleaved caspase-3 and CD276 expression were examined in nasal mucosa tissues and nasal lavage fluid (NALF) by qRT-PCR, ELISA, hematoxylin and eosin staining, western blotting, or immunohistochemistry, respectively. TUNEL assay was used to analyze nasal mucosa cells apoptosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Decreased expression of miR-29 was observed in AR, the symptoms of which were alleviated by overexpressing miR-29. In addition, overexpression of miR-29 markedly reduced the concentration of OVA-specific IgE, the levels of IL-4, IL-6, IL-10, and IFN-\u03b3, the pathological alterations and eosinophils infiltration in the nasal mucosa. Furthermore, restoration of miR-29 expression reduced nasal mucosa cell apoptosis. Moreover, overexpression of miR-29 significantly attenuated CD276 mRNA and protein levels in nasal mucosa cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MiR-29 mediated antiallergic effects in OVA-induced AR mice by decreasing inflammatory response, probably through targeting CD276. MiRNA-29 may serve as a potential novel therapeutic target for the treatment of AR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-021-00527-4","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T12:03:08Z","timestamp":1615032188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED ARTICLE: MicroRNA-29 mediates anti-inflammatory effects and alleviation of allergic responses and symptoms in mice with allergic rhinitis"],"prefix":"10.1186","volume":"17","author":[{"given":"Jia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aizhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,6]]},"reference":[{"issue":"1","key":"527_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbrc.2014.12.058","volume":"457","author":"Y Teng","year":"2015","unstructured":"Teng Y, Zhang R, Liu C, et al. miR-143 inhibits interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells from allergic rhinitis patients by targeting IL13R\u03b11. Biochem Biophys Res Commun. 2015;457(1):58\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"527_CR2","first-page":"108","volume":"8","author":"SK Wise","year":"2018","unstructured":"Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108\u2013352.","journal-title":"Int Forum Allergy Rhinol"},{"key":"527_CR3","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3389\/fimmu.2020.01747","volume":"11","author":"A Alhamwe Bilal","year":"2020","unstructured":"Alhamwe Bilal A, Sarah M, von Strandmann Elke P, et al. Epigenetic regulation of airway epithelium immune functions in asthma. Front Immunol. 2020;11:1747.","journal-title":"Front Immunol"},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphar.2019.00294","volume":"10","author":"M Watts Annabelle","year":"2019","unstructured":"Watts Annabelle M, Cripps Allan W, West Nicholas P, et al. Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents. Front Pharmacol. 2019;10:294.","journal-title":"Front Pharmacol"},{"issue":"Suppl 2","key":"527_CR5","first-page":"51","volume":"14","author":"P Small","year":"2018","unstructured":"Small P, Keith PK, Kim H. Allergic rhinitis. allergy asthma. Clin Immunol. 2018;14(Suppl 2):51.","journal-title":"Clin Immunol"},{"issue":"1","key":"527_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/cea.13192","volume":"49","author":"P Campo","year":"2019","unstructured":"Campo P, Eguiluz-Gracia I, Bogas G, et al. Local allergic rhinitis: implications for management. Clin Exp Allergy. 2019;49(1):6\u201316.","journal-title":"Clin Exp Allergy"},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphar.2019.00294","volume":"10","author":"AM Watts","year":"2019","unstructured":"Watts AM, Cripps AW, West NP, Cox AJ. Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents. Front Pharmacol. 2019;10:294.","journal-title":"Front Pharmacol"},{"issue":"1\u20132","key":"527_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cellimm.2015.09.010","volume":"298","author":"N Zhang","year":"2015","unstructured":"Zhang N, Li H, Jia J, He M. Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse. Cell Immunol. 2015;298(1\u20132):88\u201395.","journal-title":"Cell Immunol"},{"issue":"2","key":"527_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/sji.12448","volume":"84","author":"K Amin","year":"2016","unstructured":"Amin K, Janson C, Bystrom J. Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes. Scand J Immunol. 2016;84(2):75\u201385.","journal-title":"Scand J Immunol"},{"issue":"7006","key":"527_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature"},{"issue":"7","key":"527_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823\u20136.","journal-title":"Cell"},{"issue":"2","key":"527_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","volume":"428","author":"H Long","year":"2018","unstructured":"Long H, Wang X, Chen Y, Wang L, Zhao M, Lu Q. Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Lett. 2018;428:90\u2013103.","journal-title":"Cancer Lett"},{"key":"527_CR14","doi-asserted-by":"crossref","first-page":"215265672090214","DOI":"10.1177\/2152656720902142","volume":"11","author":"H Shan","year":"2020","unstructured":"Shan H, Geping W, Xiaodan G, et al. Effect of biospray dressings on eosinophil infiltration in the nasal mucosa and serum IgE levels after nasal provocation in experimental allergic rhinitis. Allergy Rhinol. 2020;11:2152656720902142.","journal-title":"Allergy Rhinol"},{"issue":"4","key":"527_CR15","first-page":"3523","volume":"15","author":"L Li","year":"2018","unstructured":"Li L, Zhang S, Jiang X, Liu Y, Liu K, Yang C. MicroRNA-let-7e regulates the progression and development of allergic rhinitis by targeting suppressor of cytokine signaling 4 and activating Janus kinase 1\/signal transducer and activator of transcription 3 pathway. Exp Ther Med. 2018;15(4):3523\u20139.","journal-title":"Exp Ther Med"},{"issue":"1","key":"527_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imr.12521","volume":"276","author":"M Janakiram","year":"2017","unstructured":"Janakiram M, Shah UA, Liu W, Zhao A, Schoenberg MP, Zang X. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7\u2013H3. Immunol Rev. 2017;276(1):26\u201339.","journal-title":"Immunol Rev"},{"issue":"4","key":"527_CR17","first-page":"66","volume":"6","author":"JR Castellanos","year":"2017","unstructured":"Castellanos JR, Purvis IJ, Labak CM, et al. B7\u2013H3 role in the immune landscape of cancer. Am J Clin Exp Immunol. 2017;6(4):66\u201375.","journal-title":"Am J Clin Exp Immunol"},{"issue":"15","key":"527_CR18","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1158\/0008-5472.CAN-08-4517","volume":"69","author":"H Xu","year":"2009","unstructured":"Xu H, Cheung IY, Guo HF, Cheung NK. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7\u2013H3: potential implications for immune based therapy of human solid tumors. Cancer Res. 2009;69(15):6275\u201381.","journal-title":"Cancer Res"},{"issue":"1","key":"527_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12967-018-1590-8","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhao X, Sun H, et al. The role of miR-29c\/B7-H3 axis in children with allergic asthma. J Transl Med. 2018;16(1):218.","journal-title":"J Transl Med"},{"issue":"9","key":"527_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.2073","volume":"12","author":"F Ma","year":"2011","unstructured":"Ma F, Xu S, Liu X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-\u03b3. Nat Immunol. 2011;12(9):861\u20139.","journal-title":"Nat Immunol"},{"issue":"4","key":"527_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00005-019-00547-4","volume":"67","author":"K Specjalski","year":"2019","unstructured":"Specjalski K, Jassem E. MicroRNAs: potential biomarkers and targets of therapy in allergic diseases? Arch Immunol Ther Exp (Warsz). 2019;67(4):213\u201323.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"527_CR22","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.biopha.2018.11.073","volume":"109","author":"TT Bui","year":"2019","unstructured":"Bui TT, Piao CH, Hyeon E, et al. The protective role of Piper nigrum fruit extract in an ovalbumin-induced allergic rhinitis by targeting of NF\u03baBp65 and STAT3 signalings. Biomed Pharmacother. 2019;109:1915\u201323.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"527_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/1744666X.2018.1504679","volume":"14","author":"A Licari","year":"2018","unstructured":"Licari A, Castagnoli R, Brambilla I, et al. Biomarkers of immunotherapy response in patients with allergic rhinitis. Expert Rev Clin Immunol. 2018;14(8):657\u201363.","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"527_CR24","doi-asserted-by":"publisher","first-page":"L621","DOI":"10.1152\/ajplung.00436.2018","volume":"316","author":"K Tang","year":"2019","unstructured":"Tang K, Zhao J, Xie J, Wang J. Decreased miR-29b expression is associated with airway inflammation in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2019;316(4):L621-l629.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"527_CR25","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1158\/1541-7786.MCR-15-0147","volume":"13","author":"SA Patel","year":"2015","unstructured":"Patel SA, Gooderham NJ. IL6 Mediates immune and colorectal cancer cell cross-talk via miR-21 and miR-29b. Mol Cancer Res. 2015;13(11):1502\u20138.","journal-title":"Mol Cancer Res"},{"issue":"47","key":"527_CR26","doi-asserted-by":"publisher","first-page":"82674","DOI":"10.18632\/oncotarget.19752","volume":"8","author":"CC Sheu","year":"2017","unstructured":"Sheu CC, Tsai MJ, Chen FW, et al. Identification of novel genetic regulations associated with airway epithelial homeostasis using next-generation sequencing data and bioinformatics approaches. Oncotarget. 2017;8(47):82674\u201388.","journal-title":"Oncotarget"},{"issue":"23","key":"527_CR27","doi-asserted-by":"publisher","first-page":"9011","DOI":"10.3390\/ijms21239011","volume":"21","author":"B \u00c9mile","year":"2020","unstructured":"\u00c9mile B, Anne-Marie M, Anne-Marie B-L, et al. Eosinophil microRNAs play a regulatory role in allergic diseases included in the atopic march. Int J Mol Sci. 2020;21(23):9011.","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"527_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejphar.2007.08.023","volume":"577","author":"H Wang","year":"2007","unstructured":"Wang H, Zhang J, Gao C, Zhu Y, Wang C, Zheng W. Topical levamisole hydrochloride therapy attenuates experimental murine allergic rhinitis. Eur J Pharmacol. 2007;577(1\u20133):162\u20139.","journal-title":"Eur J Pharmacol"},{"key":"527_CR29","doi-asserted-by":"publisher","first-page":"215265671876414","DOI":"10.1177\/2152656718764145","volume":"9","author":"KA Kim","year":"2018","unstructured":"Kim KA, Jung JH, Choi YS, Kang G, Kim ST. Anti-inflammatory effect of wogonin on allergic responses in ovalbumin-induced allergic rhinitis in the mouse. Allergy Rhinol. 2018;9:2152656718764145.","journal-title":"Allergy Rhinol"},{"key":"527_CR30","first-page":"308","volume":"32","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Feng J, Sun J, et al. H2-Eb1 expression is upregulated in the nasal mucosa of allergic rhinitis. Asian Pac J Allergy Immunol. 2014;32:308\u201315.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"527_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaci.2017.04.013","volume":"141","author":"S Takada","year":"2018","unstructured":"Takada S, Kambe N, Kawasaki Y, et al. Pluripotent stem cell models of Blau syndrome reveal an IFN-\u03b3-dependent inflammatory response in macrophages. J Allergy Clin Immunol. 2018;141(1):339-349.e311.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"527_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nri3891","volume":"15","author":"O Leavy","year":"2015","unstructured":"Leavy O. Asthma and allergy: An IFN\u03b3 bias in severe asthma. Nat Rev Immunol. 2015;15(8):466\u20137.","journal-title":"Nat Rev Immunol"},{"key":"527_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.biopha.2018.04.050","volume":"103","author":"T Wang","year":"2018","unstructured":"Wang T, Chen D, Wang P, Xu Z, Li Y. miR-375 prevents nasal mucosa cells from apoptosis and ameliorates allergic rhinitis via inhibiting JAK2\/STAT3 pathway. Biomed Pharmacother. 2018;103:621\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"527_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2567.2007.02723.x","volume":"123","author":"G Zhang","year":"2008","unstructured":"Zhang G, Hou J, Shi J, Yu G, Lu B, Zhang X. Soluble CD276 (B7\u2013H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology. 2008;123(4):538\u201346.","journal-title":"Immunology"},{"issue":"4","key":"527_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.anai.2013.06.030","volume":"111","author":"ZR Chen","year":"2013","unstructured":"Chen ZR, Zhang GB, Wang YQ, et al. Therapeutic effects of anti-B7-H3 antibody in an ovalbumin-induced mouse asthma model. Ann Allergy Asthma Immunol. 2013;111(4):276\u201381.","journal-title":"Ann Allergy Asthma Immunol"}],"updated-by":[{"DOI":"10.1186\/s13223-023-00807-1","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"record-id":"45340"},{"DOI":"10.1186\/s13223-023-00807-1","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000}}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00527-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-021-00527-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00527-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T16:08:35Z","timestamp":1686758915000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-021-00527-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s13223-021-00527-4","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,6]]},"assertion":[{"value":"19 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13223-023-00807-1","URL":"https:\/\/doi.org\/10.1186\/s13223-023-00807-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental protocols were approved by the Ethics Committee of the Beijing Shijitan Hospital of Capital Medical University (sjtkyll-lx-2020(9)). All animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}